Cargando…
GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients
In Peru, 24,581 people were diagnosed with tuberculosis (TB) in 2020. Although TB treatments are effective, 3.4–13% are associated with significant adverse drug reactions (ADRs), with drug-induced liver injury (DILI) considered the most predominant. Among the first-line antituberculosis drugs, isoni...
Autores principales: | Jaramillo-Valverde, Luis, Levano, Kelly S., Tarazona, David D., Vasquez-Dominguez, Andres, Toledo-Nauto, Anel, Capristano, Silvia, Sanchez, Cesar, Tarazona-Santos, Eduardo, Ugarte-Gil, Cesar, Guio, Heinner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569635/ https://www.ncbi.nlm.nih.gov/pubmed/36232322 http://dx.doi.org/10.3390/ijms231911028 |
Ejemplares similares
-
NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
por: Jaramillo‐Valverde, Luis, et al.
Publicado: (2022) -
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients
por: Levano, Kelly S., et al.
Publicado: (2021) -
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration
por: Jaramillo-Valverde, Luis, et al.
Publicado: (2021) -
Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire
por: Harris, Daniel N., et al.
Publicado: (2018) -
A Genomic Signature for Genotyping Mycobacterium tuberculosis
por: Tarazona, David, et al.
Publicado: (2017)